ISO-66, a novel inhibitor of macrophage migration inhibitory factor, shows efficacy in melanoma and colon cancer models

Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine, which possesses a contributing role in cancer progression and metastasis and, thus, is now considered a promising anticancer drug target. Many MIF-inactivating strategies have proven successful in delaying cance...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of oncology 2014-10, Vol.45 (4), p.1457-1468
Hauptverfasser:	IOANOU, KYRIAKI, CHENG, KAI FAN, CRICH LOW, GREGG V, BIRMPILIS, ANASTASIOS I, LO LIS, ELIAS J, TSITSILONIS, OURANIA E, AL-ABED, YOUSEF
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis cancer Care and treatment colon Colon cancer Colorectal cancer Development and progression Enzyme inhibitors Genetic aspects Health aspects ISO-66 Macrophages Medical prognosis Melanoma MIF MIF inhibitor Physiological aspects Prostate Studies Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!